发明名称 |
Stable Quick Dissolving Dosage Form Comprising Amoxicillin and Clavulanic Acid |
摘要 |
A quick dissolving pharmaceutical formulation is disclosed. In one embodiment, the formulation includes at least the following components: (1) from about 35 to about 50 weight percent amoxicillin or a pharmaceutically acceptable salt thereof; (2) from about 2.0 to about 12 weight percent clavulanic acid or a pharmaceutically acceptable salt thereof; (3) from about 30 to about 40 weight percent mannitol; (4) from about 2 to about 7 weight percent crospovidone; (5) from about 0.5 to about 2.0 weight percent colloidal silicon dioxide; and (6) from about 2.0 to about 5.0 weight percent sodium stearyl fumarate. A method for making a quick dissolving pharmaceutical tablet is also disclosed. |
申请公布号 |
US2015245995(A1) |
申请公布日期 |
2015.09.03 |
申请号 |
US201414194915 |
申请日期 |
2014.03.03 |
申请人 |
Sandoz AG |
发明人 |
Staric Rok;Oblak Marko;Rozman Peterka Tanja;Debevec Veronika |
分类号 |
A61K9/00;A61K31/424;A61K9/20;A61K47/32;A61K47/02;A61K47/12;A61K31/43;A61K47/10 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A quick dissolving pharmaceutical formulation comprising:
from about 35 to about 50 weight percent of a first active ingredient which comprises amoxicillin or a pharmaceutically acceptable salt thereof; from about 2.0 to about 12 weight percent of a second active ingredient which comprises clavulanic acid or a pharmaceutically acceptable salt thereof; from about 30 to about 40 weight percent mannitol; from about 2 to about 7 weight percent crospovidone; from about 0.5 to about 2.0 weight percent colloidal silicon dioxide; and from about 2.0 to about 5.0 weight percent sodium stearyl fumarate. |
地址 |
Basel CH |